Last reviewed · How we verify

Intracervical lidocaine

Bayero University Kano, Nigeria · FDA-approved active Small molecule

Intracervical lidocaine is a Local anesthetic Small molecule drug developed by Bayero University Kano, Nigeria. It is currently FDA-approved for Cervical anesthesia during gynecological procedures, Pain relief during cervical examination or instrumentation. Also known as: lignocaine, Lidocaine injection, paracervical blocker.

Intracervical lidocaine is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission in cervical tissue.

Intracervical lidocaine is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission in cervical tissue. Used for Cervical anesthesia during gynecological procedures, Pain relief during cervical examination or instrumentation.

At a glance

Generic nameIntracervical lidocaine
Also known aslignocaine, Lidocaine injection, paracervical blocker
SponsorBayero University Kano, Nigeria
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaGynecology / Pain management
PhaseFDA-approved

Mechanism of action

Lidocaine works by inhibiting the influx of sodium ions through voltage-gated sodium channels in nerve fibers, thereby preventing depolarization and the generation of action potentials. When applied intracervically, it produces localized anesthesia of the cervix and surrounding tissues, reducing pain sensation during gynecological procedures or examinations.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Intracervical lidocaine

What is Intracervical lidocaine?

Intracervical lidocaine is a Local anesthetic drug developed by Bayero University Kano, Nigeria, indicated for Cervical anesthesia during gynecological procedures, Pain relief during cervical examination or instrumentation.

How does Intracervical lidocaine work?

Intracervical lidocaine is a local anesthetic that blocks sodium channels in nerve cell membranes to prevent pain signal transmission in cervical tissue.

What is Intracervical lidocaine used for?

Intracervical lidocaine is indicated for Cervical anesthesia during gynecological procedures, Pain relief during cervical examination or instrumentation.

Who makes Intracervical lidocaine?

Intracervical lidocaine is developed and marketed by Bayero University Kano, Nigeria (see full Bayero University Kano, Nigeria pipeline at /company/bayero-university-kano-nigeria).

Is Intracervical lidocaine also known as anything else?

Intracervical lidocaine is also known as lignocaine, Lidocaine injection, paracervical blocker.

What drug class is Intracervical lidocaine in?

Intracervical lidocaine belongs to the Local anesthetic class. See all Local anesthetic drugs at /class/local-anesthetic.

What development phase is Intracervical lidocaine in?

Intracervical lidocaine is FDA-approved (marketed).

What are the side effects of Intracervical lidocaine?

Common side effects of Intracervical lidocaine include Local irritation or burning at application site, Allergic reaction (rare with amide lidocaine), Systemic toxicity (if absorbed in high amounts).

What does Intracervical lidocaine target?

Intracervical lidocaine targets Voltage-gated sodium channels and is a Local anesthetic.

Related